Abstract
Small heat shock proteins(sHSPs), with a small molecular mass of 12-43 kDa, are molecular chaperones that protect cells against stress by assisting them in the correct folding of denatured proteins and thus prevent aggregation of misfolded proteins. During the past several years, there has been an increasing interest in the relationship between sHSPs and neuropathy. sHSPs have emerged as a particularly potent neuroprotectant in diverse neurological disorders. Therefor, in this review, we will focus on the expression of sHSPs in different neurological disorders, and discuss the recent findings of the biological implications of sHSPs in physiological and pathological processes in these diseases. Novel therapeutic strategies aiming at restoring sHSPs in neuropathy will also be presented.
Keywords: Cerebral ischemia, demyelination diseases, neurodegenerative disorders, neuropathy, seizures, small heat shock proteins(sHSPs)
Current Neurovascular Research
Title: Small Heat Shock Proteins: Recent Advances in Neuropathy
Volume: 7 Issue: 2
Author(s): Liuwang Zeng, Zhiping Hu, Wei Lu, Xiangqi Tang, Jie Zhang, Ting Li and Binbin Yang
Affiliation:
Keywords: Cerebral ischemia, demyelination diseases, neurodegenerative disorders, neuropathy, seizures, small heat shock proteins(sHSPs)
Abstract: Small heat shock proteins(sHSPs), with a small molecular mass of 12-43 kDa, are molecular chaperones that protect cells against stress by assisting them in the correct folding of denatured proteins and thus prevent aggregation of misfolded proteins. During the past several years, there has been an increasing interest in the relationship between sHSPs and neuropathy. sHSPs have emerged as a particularly potent neuroprotectant in diverse neurological disorders. Therefor, in this review, we will focus on the expression of sHSPs in different neurological disorders, and discuss the recent findings of the biological implications of sHSPs in physiological and pathological processes in these diseases. Novel therapeutic strategies aiming at restoring sHSPs in neuropathy will also be presented.
Export Options
About this article
Cite this article as:
Zeng Liuwang, Hu Zhiping, Lu Wei, Tang Xiangqi, Zhang Jie, Li Ting and Yang Binbin, Small Heat Shock Proteins: Recent Advances in Neuropathy, Current Neurovascular Research 2010; 7 (2) . https://dx.doi.org/10.2174/156720210791184934
DOI https://dx.doi.org/10.2174/156720210791184934 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Quinoline Derivatives: Candidate Drugs for a Class B G-Protein Coupled Receptor, the Calcitonin Gene-Related Peptide Receptor, a Cause of Migraines
CNS & Neurological Disorders - Drug Targets Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases
CNS & Neurological Disorders - Drug Targets Homocysteine in Neurological Disease: A Marker or a Cause?
CNS & Neurological Disorders - Drug Targets Multitarget Network Strategies to Influence Memory and Forgetting: The Ras/Mapk Pathway as a Novel Option
Mini-Reviews in Medicinal Chemistry Targeting Protein-Protein Interactions in the Proteasome Super-Assemblies.
Current Topics in Medicinal Chemistry Cross-Talk Between NO Synthase Isoforms in Neuro-Inflammation: Possible Implications in HIV-Associated Neurocognitive Disorders
Current Medicinal Chemistry Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities
Current Neuropharmacology Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
Current Medicinal Chemistry The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model
Current Pharmaceutical Design Nanoceria: Synthesis and Biomedical Applications
Current Nanoscience Targeting Hsp90 in Non-Cancerous Maladies
Current Topics in Medicinal Chemistry The Complex Actions of Statins in Brain and their Relevance for Alzheimer`s Disease Treatment: An Analytical Review
Current Alzheimer Research Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery (Discontinued) Cell Life Versus Cell Longevity: The Mysteries Surrounding the NAD+ Precursor Nicotinamide
Current Medicinal Chemistry Acetylome Regulation by Sirtuins in the Brain: From Normal Physiology to Aging and Pathology
Current Pharmaceutical Design Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer’s Disease: A Study of EEG-Derived Brain Activity
Current Alzheimer Research Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders
Mini-Reviews in Medicinal Chemistry Heat Shock Proteins and Ion Channels. Functional Interactions and Therapeutic Consequences
Current Pharmaceutical Biotechnology